Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vse (VSEC) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Vse (VSEC) over the last 17 years, with Q3 2025 value amounting to $8.8 million.

  • Vse's Cash & Equivalents rose 1109.14% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 million, marking a year-over-year increase of 1109.14%. This contributed to the annual value of $29.5 million for FY2024, which is 27982.75% up from last year.
  • Per Vse's latest filing, its Cash & Equivalents stood at $8.8 million for Q3 2025, which was up 1109.14% from $16.9 million recorded in Q2 2025.
  • In the past 5 years, Vse's Cash & Equivalents registered a high of $29.5 million during Q4 2024, and its lowest value of $90000.0 during Q3 2022.
  • Moreover, its 5-year median value for Cash & Equivalents was $4.2 million (2023), whereas its average is $7.1 million.
  • Per our database at Business Quant, Vse's Cash & Equivalents plummeted by 7650.13% in 2022 and then soared by 2286333.33% in 2023.
  • Quarter analysis of 5 years shows Vse's Cash & Equivalents stood at $518000.0 in 2021, then tumbled by 41.12% to $305000.0 in 2022, then soared by 2446.89% to $7.8 million in 2023, then soared by 279.83% to $29.5 million in 2024, then plummeted by 70.23% to $8.8 million in 2025.
  • Its Cash & Equivalents stands at $8.8 million for Q3 2025, versus $16.9 million for Q2 2025 and $5.7 million for Q1 2025.